Trial intelligence / Profile preview

Phenytoin spray for prevention of palatal fistula after cleft palate surgery in children

IRCT20180802040678N3Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of phenytoin in cleft palate (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Palate fistula formation. Started Mar 2010; status: completed.

02

Drugs

phenytoin
03

Conditions

cleft palate

Beyond the preview

Go deeper on IRCT20180802040678N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180802040678N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call